Enrique Martin-Gayo1, Xu G Yu2. 1. Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, 400 Technology Square, Cambridge, MA, 02139, USA. 2. Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, 400 Technology Square, Cambridge, MA, 02139, USA. xyu@mgh.harvard.edu.
Abstract
PURPOSE OF REVIEW: Robust HIV-1-specific CD8 T cell responses are currently regarded as the main correlate of immune defense in rare individuals who achieve natural, drug-free control of HIV-1; however, the mechanisms that support evolution of such powerful immune responses are not well understood. Dendritic cells (DCs) are specialized innate immune cells critical for immune recognition, immune regulation, and immune induction, but their possible contribution to HIV-1 immune defense in controllers remains ill-defined. RECENT FINDINGS: Recent studies suggest that myeloid DCs from controllers have improved abilities to recognize HIV-1 through cytoplasmic immune sensors, resulting in more potent, cell-intrinsic type I interferon secretion in response to viral infection. This innate immune response may facilitate DC-mediated induction of highly potent antiviral HIV-1-specific T cells. Moreover, protective HLA class I isotypes restricting HIV-1-specific CD8 T cells may influence DC function through specific interactions with innate myelomonocytic MHC class I receptors from the leukocyte immunoglobulin-like receptor family. Bi-directional interactions between dendritic cells and HIV-1-specific T cells may contribute to natural HIV-1 immune control, highlighting the importance of a fine-tuned interplay between innate and adaptive immune activities for effective antiviral immune defense.
PURPOSE OF REVIEW: Robust HIV-1-specific CD8 T cell responses are currently regarded as the main correlate of immune defense in rare individuals who achieve natural, drug-free control of HIV-1; however, the mechanisms that support evolution of such powerful immune responses are not well understood. Dendritic cells (DCs) are specialized innate immune cells critical for immune recognition, immune regulation, and immune induction, but their possible contribution to HIV-1 immune defense in controllers remains ill-defined. RECENT FINDINGS: Recent studies suggest that myeloid DCs from controllers have improved abilities to recognize HIV-1 through cytoplasmic immune sensors, resulting in more potent, cell-intrinsic type I interferon secretion in response to viral infection. This innate immune response may facilitate DC-mediated induction of highly potent antiviral HIV-1-specific T cells. Moreover, protective HLA class I isotypes restricting HIV-1-specific CD8 T cells may influence DC function through specific interactions with innate myelomonocytic MHC class I receptors from the leukocyte immunoglobulin-like receptor family. Bi-directional interactions between dendritic cells and HIV-1-specific T cells may contribute to natural HIV-1 immune control, highlighting the importance of a fine-tuned interplay between innate and adaptive immune activities for effective antiviral immune defense.
Authors: Olivier Manches; Melissa Victoria Fernandez; Joel Plumas; Laurence Chaperot; Nina Bhardwaj Journal: Proc Natl Acad Sci U S A Date: 2012-08-09 Impact factor: 11.205
Authors: Zaza M Ndhlovu; Lori B Chibnik; Jacqueline Proudfoot; Seanna Vine; Ashley McMullen; Kevin Cesa; Filippos Porichis; R Brad Jones; Donna Marie Alvino; Meghan G Hart; Eleni Stampouloglou; Alicja Piechocka-Trocha; Carl Kadie; Florencia Pereyra; David Heckerman; Philip L De Jager; Bruce D Walker; Daniel E Kaufmann Journal: Blood Date: 2012-12-11 Impact factor: 22.113
Authors: Christian Bode; Mario Fox; Poonam Tewary; Almut Steinhagen; Richard K Ellerkmann; Dennis Klinman; Georg Baumgarten; Veit Hornung; Folkert Steinhagen Journal: Eur J Immunol Date: 2016-05-27 Impact factor: 5.532
Authors: Benoît Vingert; Daniela Benati; Olivier Lambotte; Pierre de Truchis; Laurence Slama; Patricia Jeannin; Moran Galperin; Santiago Perez-Patrigeon; Faroudy Boufassa; William W Kwok; Fabrice Lemaître; Jean-François Delfraissy; Jacques Thèze; Lisa A Chakrabarti Journal: J Virol Date: 2012-07-25 Impact factor: 5.103
Authors: Marta Calvet-Mirabent; Ildefonso Sánchez-Cerrillo; Noa Martín-Cófreces; Pedro Martínez-Fleta; Hortensia de la Fuente; Ilya Tsukalov; Cristina Delgado-Arévalo; María José Calzada; Ignacio de Los Santos; Jesús Sanz; Lucio García-Fraile; Francisco Sánchez-Madrid; Arantzazu Alfranca; María Ángeles Muñoz-Fernández; Maria J Buzón; Enrique Martín-Gayo Journal: EBioMedicine Date: 2022-06-02 Impact factor: 11.205